Rumors re: Purdue's DOJ Deal

in

On October 7, Reuters reported that Purdue Pharma and the DOJ are nearing completion of a deal that’d resolve all of the company’s federal investigations and criminal probes. Just one week later, 25 state Attorneys General sent a letter to U.S. Attorney General William Barr expressing their disapproval of the DOJ’s condition that Purdue “be preserved as a ‘public benefit company’ that will sell OxyContin on behalf of cities and state governments.” The mostly Democratic AG-signatories include those from Connecticut, Massachusetts, and New York.

  • If you’re curious about how this affects Purdue’s bankruptcy proceedings, check out this site’s take here.

  • If you think Trump had a hand in any of this, check out the update from October 4, 2020.